Late Assessment of Thrombolytic Efficacy (LATE) study with al- teplase 6 24 hours after onset of acute myocardial infarction. Lancet. 1993;342:759 66. 310. Rossi P, Bolognese L. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction: Urochinasi per via Sistemica nell Infarto Miocardico (USIM) Collaborative Group. Am J Cardiol. 1991;68:585 92. 311. The I.S.A.M. Study Group. A prospective trial of Intravenous Streptoki- nase in Acute Myocardial infarction (I.S.A.M.): mortality, morbidity, and infarct size at 21 days. N Engl J Med. 1986;314:1465 71. 312. The TIMI IIIA Investigators. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest: results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation. 1993;87:38 52. 313. Barrab s JA, Figueras J, Moure C, et al. Prognostic value of lead aVR in patients with a first non-ST-segment elevation acute myocardial infarc- tion. Circulation. 2003;108:814 9. 314. Bode C, Smalling RW, Berg G, et al; RAPID II Investigators. Random- ized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, acceler- ated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. Circulation. 1996;94:891 8. 315. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plas- minogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lan- cet. 1992;339:753 70. 316. Llevadot J, Giugliano RP, Antman EM. Bolus fibrinolytic therapy in acute myocardial infarction. JAMA. 2001;286:442 9. 317. The Global Use of Strategies to Open Occluded CoronaryArteries (GUS- TO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med. 1997;337:1118 23. 318. The GUSTO Investigators. 